Expedited Partner Therapy (EPT) for Sexually Transmitted Infections: A Resource for California Health Care Providers
Expedited Partner Therapy (EPT) is the clinical practice of treating sex partners of patients diagnosed with treatable sexually transmitted infections (STIs) – including chlamydia, gonorrhea, and trichomoniasis – without the health care provider first examining the partner(s).
This document explains what EPT is and why clinicians in California should prescribe it. In-depth references are also provided.
This guide was developed by our partners at the National Coalition for Sexual Health.
Sexual Health and Your Patients: A Provider’s Guide can help healthcare providers better integrate sexual health conversations and recommended preventive services into routine visits with adolescents and adults. By using this guide, providers can:
Become more knowledgeable about sexual health
Streamline their sexual history taking
Increase their delivery of recommended preventive sexual health services by using “at a glance” tables
Improve their care for LGBTQ+ patients
Be better prepared to discuss sexual health topics and answer patient questions
April 2022 Seminar on PrEP Financing and Logistics
April 28, 2022
Opt-Out ED Screening for HIV, HCV, and Syphilis—Dear Colleague Letter from CDPH
March 28, 2022: Emergency departments (EDs) are uniquely positioned to identify people with syphilis, HIV, and hepatitis C who otherwise might remain undiagnosed. The California Department of Public Health (CDPH) recommends that EDs consider implementing routine opt-out testing for syphilis, HIV, and hepatitis C.
Identification and immediate treatment through the ED may have the added benefit of furthering health equity for those disproportionately affected by these infections
Home
Training 2021 CDC STI Treatment Guidelines Update: What’s New
2021 CDC STI Treatment Guidelines Update: What’s New
December 10, 2021
Presented by Drs. Sharon Adler and Kelly Johnson
Learn more about the 2021 CDC STI Treatment Guidelines. Updated every 4-5 years, CDC’s STI Treatment Guidelines provide current evidence-based diagnostic, management, and treatment recommendations, and serve as a source of clinical guidance for managing sexually transmitted infections (STIs). This webinar will cover 2021 changes.
Learning Objectives
Learn about and become proficient with the treatment updates
Discuss and be able to share the rationale for the updates
Understand the changes needed and apply them to clinical practice
2021 PrEP Clinical Practice Guideline – Clinical Providers’ Supplement
Comprehensive information for the use of antiretroviral preexposure prophylaxis (PrEP) to prevent acquiring HIV infection.
Updates for 2021 include:
A recommendation to inform all sexually active adults and adolescents about PrEP
PrEP with intramuscular cabotegravir (CAB) injections (conditional on FDA approval) is recommended for HIV prevention in adults reporting sexual behaviors that place them at substantial ongoing risk of HIV exposure and acquisition.
Comprehensive information for the use of antiretroviral preexposure prophylaxis (PrEP) to prevent acquiring HIV infection.
Updates for 2021 include:
A recommendation to inform all sexually active adults and adolescents about PrEP
PrEP with intramuscular cabotegravir (CAB) injections (conditional on FDA approval) is recommended for HIV prevention in adults reporting sexual behaviors that place them at substantial ongoing risk of HIV exposure and acquisition.
We use cookies to ensure that we give you the best experience on our website, but we also recognize the right to privacy. Please accept or disable cookies for this website.
